In agreement with IKBKE depletion, pharmacological antagonism of IKBKE in multiple PC cell lines, resulted in a significant and dose dependent decrease in cellular growth, as assessed by live cell imaging (Figure 7C) or alternatively sulforhodamine B growth assays (Supplementary Figure S6B–D). The gene discussed is IKBKE; the disease is pachyonychia congenita.